2022
DOI: 10.1055/s-0041-1741072
|View full text |Cite
|
Sign up to set email alerts
|

Thrombosis and Haemostasis 2021 Editors' Choice Papers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

2
0

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 98 publications
0
2
0
Order By: Relevance
“…In the Editor's Choice from last year, we already mentioned the challenge that represents East Asian patients as bleeding risk in this population is higher than in people from Western countries. 21,22 Indeed, our publication of an expert consensus paper from Europe and Asia-Pacific on the topic of bleeding risk assessment is timely. 23 The importance of the ABC pathway among other recommendations such as the relevance of non-vitamin K antagonist oral anticoagulants over vitamin K antagonist has been stressed again in the new updated consensus guidelines of the Asia-Pacific Heart Rhythm Society on stroke prevention in AF.…”
Section: Diagnosis and Management Of Atrial Fibrillationmentioning
confidence: 99%
“…In the Editor's Choice from last year, we already mentioned the challenge that represents East Asian patients as bleeding risk in this population is higher than in people from Western countries. 21,22 Indeed, our publication of an expert consensus paper from Europe and Asia-Pacific on the topic of bleeding risk assessment is timely. 23 The importance of the ABC pathway among other recommendations such as the relevance of non-vitamin K antagonist oral anticoagulants over vitamin K antagonist has been stressed again in the new updated consensus guidelines of the Asia-Pacific Heart Rhythm Society on stroke prevention in AF.…”
Section: Diagnosis and Management Of Atrial Fibrillationmentioning
confidence: 99%
“…As with our traditional new year's message, we aim to summarize our journey in the last year and look forward to 2023. [1][2][3][4] Another year has quickly passed, and as we emerge into more (three-dimensional) in-person meetings rather than the two-dimensional virtual meetings of various platforms, the journal also continues to grow.…”
mentioning
confidence: 99%